OBJECTIVE: To determine whether early identification of physiologic variances associated with interstage death would reduce mortality, we developed a home surveillance program. METHODS: Patients discharged before initiation of home surveillance (group A, n = 63) were compared with patients discharged with an infant scale and pulse oximeter (group B, n = 24). Parents maintained a daily log of weight and arterial oxygen saturation according to pulse oximetry and were instructed to contact their physician in case of an arterial oxygen saturation less than 70% according to pulse oximetry, an acute weight loss of more than 30 g in 24 hours, or failure to gain at least 20 g during a 3-day period. RESULTS: Interstage mortality among infants surviving to discharge was 15.8% (n = 9/57) in group A and 0% (n = 0/24) in group B (P =.039). Surveillance criteria were breached for 13 of 24 group B patients: 12 patients with decreased arterial oxygen saturation according to pulse oximetry with or without poor weight gain and 1 patient with poor weight gain alone. These 13 patients underwent bidirectional superior cavopulmonary connection (stage 2 palliation) at an earlier age, 3.7 +/- 1.1 months of age versus 5.2 +/- 2.0 months for patients with an uncomplicated interstage course (P =.028). A growth curve was generated and showed reduced growth velocity between 4 and 5 months of age, with a plateau in growth beyond 5 months of age. CONCLUSION: Daily home surveillance of arterial oxygen saturation according to pulse oximetry and weight selected patients at increased risk of interstage death, permitting timely intervention, primarily with early stage 2 palliation, and was associated with improved interstage survival. Diminished growth identified 4 to 5 months after the Norwood procedure brings into question the value of delaying stage 2 palliation beyond 5 months of age.
OBJECTIVE: To determine whether early identification of physiologic variances associated with interstage death would reduce mortality, we developed a home surveillance program. METHODS:Patients discharged before initiation of home surveillance (group A, n = 63) were compared with patients discharged with an infant scale and pulse oximeter (group B, n = 24). Parents maintained a daily log of weight and arterial oxygen saturation according to pulse oximetry and were instructed to contact their physician in case of an arterial oxygen saturation less than 70% according to pulse oximetry, an acute weight loss of more than 30 g in 24 hours, or failure to gain at least 20 g during a 3-day period. RESULTS: Interstage mortality among infants surviving to discharge was 15.8% (n = 9/57) in group A and 0% (n = 0/24) in group B (P =.039). Surveillance criteria were breached for 13 of 24 group B patients: 12 patients with decreased arterial oxygen saturation according to pulse oximetry with or without poor weight gain and 1 patient with poor weight gain alone. These 13 patients underwent bidirectional superior cavopulmonary connection (stage 2 palliation) at an earlier age, 3.7 +/- 1.1 months of age versus 5.2 +/- 2.0 months for patients with an uncomplicated interstage course (P =.028). A growth curve was generated and showed reduced growth velocity between 4 and 5 months of age, with a plateau in growth beyond 5 months of age. CONCLUSION: Daily home surveillance of arterial oxygen saturation according to pulse oximetry and weight selected patients at increased risk of interstage death, permitting timely intervention, primarily with early stage 2 palliation, and was associated with improved interstage survival. Diminished growth identified 4 to 5 months after the Norwood procedure brings into question the value of delaying stage 2 palliation beyond 5 months of age.
Authors: Julia Fischbach; Nicodème Sinzobahamvya; Christoph Haun; Ehrenfried Schindler; Peter Zartner; Martin Schneider; Viktor Hraška; Boulos Asfour; Joachim Photiadis Journal: Pediatr Cardiol Date: 2012-06-04 Impact factor: 1.655
Authors: Dongngan T Truong; Shaji C Menon; Linda M Lambert; Phillip T Burch; Xiaoming Sheng; L LuAnn Minich; Richard V Williams Journal: Pediatr Cardiol Date: 2018-05-24 Impact factor: 1.655
Authors: Humera Ahmed; Jeffrey B Anderson; Katherine E Bates; Shobha Natarajan; Nancy S Ghanayem; Carole M Lannon; David W Brown Journal: Pediatr Cardiol Date: 2021-05-04 Impact factor: 1.655
Authors: Walter Knirsch; Sonia Bertholdt; Gaby Stoffel; Brian Stiasny; Roland Weber; Hitendu Dave; Rene Prêtre; Michael von Rhein; Oliver Kretschmar Journal: Pediatr Cardiol Date: 2014-01-18 Impact factor: 1.655
Authors: Linda M Lambert; Nancy A Pike; Barbara Medoff-Cooper; Victor Zak; Victoria L Pemberton; Lisa Young-Borkowski; Martha L Clabby; Kathryn N Nelson; Richard G Ohye; Bethany Trainor; Karen Uzark; Nancy Rudd; Louise Bannister; Rosalind Korsin; David S Cooper; Christian Pizarro; Sinai C Zyblewski; Bronwyn H Bartle; Richard V Williams Journal: J Pediatr Date: 2013-11-06 Impact factor: 4.406
Authors: Richard G Ohye; Julie V Schonbeck; Pirooz Eghtesady; Peter C Laussen; Christian Pizarro; Peter Shrader; Deborah U Frank; Eric M Graham; Kevin D Hill; Jeffrey P Jacobs; Kirk R Kanter; Joel A Kirsh; Linda M Lambert; Alan B Lewis; Chitra Ravishankar; James S Tweddell; Ismee A Williams; Gail D Pearson Journal: J Thorac Cardiovasc Surg Date: 2012-08-15 Impact factor: 5.209